86 related articles for article (PubMed ID: 1683040)
21. Restriction fragment length polymorphisms of the human N-myc gene in normal healthy individuals and oral cancer patients in India.
Saranath D; Panchal RG; Deo MG; Sanghvi V; Mehta AR
Indian J Biochem Biophys; 1994 Jun; 31(3):177-83. PubMed ID: 7959843
[TBL] [Abstract][Full Text] [Related]
22. L-myc polymorphism in head and neck nonmelanoma skin and lower lip cancers.
Gözü A; Ergen A; Dayicioglu D; Yaylim I; Ozsoy Z; Isbir T
Arch Otolaryngol Head Neck Surg; 2008 Jul; 134(7):725-8. PubMed ID: 18645122
[TBL] [Abstract][Full Text] [Related]
23. The protease activated receptor 1 gene variation IVSn -14 A>T is associated with distant metastasis and cancer specific survival in renal cell carcinoma.
de Martino M; Haitel A; Schatzl G; Klatte T
J Urol; 2013 Oct; 190(4):1392-7. PubMed ID: 23517743
[TBL] [Abstract][Full Text] [Related]
24. Restriction fragment length polymorphism analysis of the L-myc gene locus in a case-control study of lung cancer.
Tamai S; Sugimura H; Caporaso NE; Resau JH; Trump BF; Weston A; Harris CC
Int J Cancer; 1990 Sep; 46(3):411-5. PubMed ID: 1975565
[TBL] [Abstract][Full Text] [Related]
25. [S allele of the L-myc oncogene is associated with lung cancer metastases in patients from Moldova].
Chernitsa OI; Togo AV; Shutkin VA; Khanson KP; Imianitov EN
Vopr Onkol; 1998; 44(1):33-6. PubMed ID: 9578728
[TBL] [Abstract][Full Text] [Related]
26. Rflp analysis of the L-myc oncogene in head and neck-cancer - relationship study with susceptibility and disease progression.
Millon R; Muller D; Velten M; Doffoel S; Eber M; Engelmann A; Bronner G; Flesch H; Methlin G; Abecassis J
Int J Oncol; 1995 Jan; 6(1):237-42. PubMed ID: 21556529
[TBL] [Abstract][Full Text] [Related]
27. Overexpression and amplification of c-myc in the Syrian hamster kidney during estrogen carcinogenesis: a probable critical role in neoplastic transformation.
Li JJ; Hou X; Banerjee SK; Liao DZ; Maggouta F; Norris JS; Li SA
Cancer Res; 1999 May; 59(10):2340-6. PubMed ID: 10344741
[TBL] [Abstract][Full Text] [Related]
28. Role of L-MYC polymorphism in oral squamous cell carcinoma in Turkey.
Bektas-Kayhan K; Unür M; Yaylim-Eraltan I; Ergen A; Hafiz G; Karadeniz A; Isbir T
Anticancer Res; 2009 Jul; 29(7):2519-24. PubMed ID: 19596922
[TBL] [Abstract][Full Text] [Related]
29. Allelic losses at chromosome 17p in human renal cell carcinoma are inversely related to allelic losses at chromosome 3p.
Ogawa O; Habuchi T; Kakehi Y; Koshiba M; Sugiyama T; Yoshida O
Cancer Res; 1992 Apr; 52(7):1881-5. PubMed ID: 1348014
[TBL] [Abstract][Full Text] [Related]
30. [Association studies in cancerology: the example of gene L-myc polymorphism associated with the incidence of pulmonary metastases in breast cancers].
Champème MH; Bièche I; Latil A; Hacène K; Lidereau R
Bull Cancer; 1992; 79(12):1149-57. PubMed ID: 1304834
[TBL] [Abstract][Full Text] [Related]
31. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization.
Jenkins RB; Qian J; Lieber MM; Bostwick DG
Cancer Res; 1997 Feb; 57(3):524-31. PubMed ID: 9012485
[TBL] [Abstract][Full Text] [Related]
32. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
[TBL] [Abstract][Full Text] [Related]
33. Common regions of deletion on chromosomes 5q, 6q, and 10q in renal cell carcinoma.
Morita R; Saito S; Ishikawa J; Ogawa O; Yoshida O; Yamakawa K; Nakamura Y
Cancer Res; 1991 Nov; 51(21):5817-20. PubMed ID: 1682036
[TBL] [Abstract][Full Text] [Related]
34. Analysis of L-myc gene polymorphism in patients with renal failure outcome to renal transplant.
Yigit B; Bozkurt N; Yaylim I; Titiz I; Isbir T
Transplant Proc; 2006 Jun; 38(5):1267-9. PubMed ID: 16797278
[TBL] [Abstract][Full Text] [Related]
35. Restriction fragment length polymorphism of the L-myc gene is not a prognostic factor in bladder cancer patients.
Ejarque MJ; Vicente M; Bernués M; Oliver A; Vicente J; Capellá G; Lluís F; Chéchile G
Br J Cancer; 1999 Apr; 79(11-12):1855-8. PubMed ID: 10206304
[TBL] [Abstract][Full Text] [Related]
36. Apolipoprotein A1 -75 G/A and +83 C/T polymorphisms and renal cancer risk.
Liu Z; Xiao Y; Tang L; Jiang L; Wang Y; Zhang R; Wei Q; Lu Y
Lipids Health Dis; 2015 Nov; 14():143. PubMed ID: 26537097
[TBL] [Abstract][Full Text] [Related]
37. PCR-based RFLP screening of the commonly deleted 3p loci in renal cortical neoplasms.
el-Naggar AK; Batsakis JG; Wang G; Lee MS
Diagn Mol Pathol; 1993 Dec; 2(4):269-76. PubMed ID: 7906993
[TBL] [Abstract][Full Text] [Related]
38. MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.
Heinzelmann J; Unrein A; Wickmann U; Baumgart S; Stapf M; Szendroi A; Grimm MO; Gajda MR; Wunderlich H; Junker K
Ann Surg Oncol; 2014 Mar; 21(3):1046-54. PubMed ID: 24242678
[TBL] [Abstract][Full Text] [Related]
39. Mitochondrial and chromosomal DNA alterations in human chromophobe renal cell carcinomas.
Kovacs A; Storkel S; Thoenes W; Kovacs G
J Pathol; 1992 Jul; 167(3):273-7. PubMed ID: 1381433
[TBL] [Abstract][Full Text] [Related]
40. L-myc gene polymorphism and risk of thyroid cancer.
Yaylim-Eraltan I; Bozkurt N; Ergen A; Zeybek U; Ozturk O; Arikan S; Erbil Y; Uslu I; Camlica H; Isbir T
Exp Oncol; 2008 Jun; 30(2):117-20. PubMed ID: 18566574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
